Abstract
We report the onset of dermatomyositis in a woman pregnant 38-weeks who subsequently delivered a healthy infant. The disease improved rapidly following delivery. The association of dermatomyositis with pregnancy is unusual, and fetal outcome may be adversely affected.
MeSH terms
-
Adult
-
Anti-Inflammatory Agents / therapeutic use
-
Dermatomyositis / drug therapy*
-
Dermatomyositis / pathology
-
Drug Therapy, Combination
-
Female
-
Humans
-
Methylprednisolone / therapeutic use
-
Prednisolone / therapeutic use
-
Pregnancy
-
Pregnancy Complications / drug therapy*
-
Pregnancy Complications / pathology
Substances
-
Anti-Inflammatory Agents
-
Prednisolone
-
Methylprednisolone